Celularity Profit Margin

Celularity (CELU) currently reports a profit margin of -345.44% as of December 2025. That compares with -131.65% in the prior-year period — down 162.4% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Celularity's profit margin history and peer comparisons.

Celularity's profit margin decreased from -131.65% to -345.44% — a 162.4% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Celularity's profit margin of -345.44% is lower than the Healthcare sector average of 13.89%. That is roughly 2587.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Celularity's current -345.44% should be judged against Healthcare norms (sector average: 13.89%) and against CELU's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -345.44%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Celularity, and consider following CELU for alerts when major investors trade the stock.